IndustryPayments

SARA CHILDRESS WEAVER

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care DANVILLE, VA NPI 1669016044

Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care VA NOVARTIS PHARMACEUTICALS CORPORATION All categories

General Payments — all program years on this page

$3,311.50

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 185
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $827.26 across 48 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $827.2648

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $176.5015
Acerta Pharma LLC $118.655
Kiniksa Pharmaceuticals International, plc $105.545
E.R. Squibb & Sons, L.L.C. $78.235
Novo Nordisk AS $55.373
Philips Electronics North America Corporation $42.041
United Therapeutics Corporation $37.522
Janssen Pharmaceuticals, Inc $36.382
Boehringer Ingelheim Pharmaceuticals, Inc. $33.592
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $33.382
Esperion Therapeutics, Inc. $32.922
Lexicon Pharmaceuticals, Inc. $24.741
Merck Sharp & Dohme Corporation $18.031
Daiichi Sankyo Inc. $17.391
Alnylam Pharmaceuticals Inc. $16.981

By program year

Program yearAmountRecords
2021 $601.0036
2022 $926.2054
2023 $957.0447
2024 $827.2648

Records — PY2024 (48)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078238107 Janssen Pharmaceuticals, Inc $17.48 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078238145 Janssen Pharmaceuticals, Inc $18.90 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080694656 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $22.78 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080694676 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $10.60 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081710943 Lexicon Pharmaceuticals, Inc. $24.74 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357744 Novartis Pharmaceuticals Corporation $14.34 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357754 Novartis Pharmaceuticals Corporation $14.31 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357756 Novartis Pharmaceuticals Corporation $0.61 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357758 Novartis Pharmaceuticals Corporation $1.16 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357760 Novartis Pharmaceuticals Corporation $15.18 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357766 Novartis Pharmaceuticals Corporation $25.16 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357776 Novartis Pharmaceuticals Corporation $0.83 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357778 Novartis Pharmaceuticals Corporation $15.32 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357784 Novartis Pharmaceuticals Corporation $15.69 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357786 Novartis Pharmaceuticals Corporation $0.90 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357796 Novartis Pharmaceuticals Corporation $18.76 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357804 Novartis Pharmaceuticals Corporation $0.70 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357806 Novartis Pharmaceuticals Corporation $14.66 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357808 Novartis Pharmaceuticals Corporation $17.70 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087357810 Novartis Pharmaceuticals Corporation $21.18 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089496948 Daiichi Sankyo Inc. $17.39 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100226116 Novo Nordisk Inc $18.33 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100314569 Novo Nordisk Inc $18.56 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100564228 Novo Nordisk Inc $18.48 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101234185 E.R. Squibb & Sons, L.L.C. $14.99 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101234191 E.R. Squibb & Sons, L.L.C. $16.68 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101234205 E.R. Squibb & Sons, L.L.C. $16.31 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101234219 E.R. Squibb & Sons, L.L.C. $15.10 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101234227 E.R. Squibb & Sons, L.L.C. $15.15 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104478068 AstraZeneca Pharmaceuticals LP $26.00 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104490492 AstraZeneca Pharmaceuticals LP $16.61 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104499710 AstraZeneca Pharmaceuticals LP $24.07 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104612198 AstraZeneca Pharmaceuticals LP $25.80 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105217381 AstraZeneca Pharmaceuticals LP $26.17 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118101218 Boehringer Ingelheim Pharmaceuticals, Inc. $15.07 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118101220 Boehringer Ingelheim Pharmaceuticals, Inc. $18.52 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125850014 Alnylam Pharmaceuticals Inc. $16.98 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129478642 Esperion Therapeutics, Inc. $13.69 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129478644 Esperion Therapeutics, Inc. $19.23 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141913860 Merck Sharp & Dohme LLC $18.03 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146910738 Philips North America LLC $42.04 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149453582 United Therapeutics Corporation $18.38 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149466530 United Therapeutics Corporation $19.14 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154897416 Kiniksa Pharmaceuticals International, plc $22.10 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154897444 Kiniksa Pharmaceuticals International, plc $24.14 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154897468 Kiniksa Pharmaceuticals International, plc $19.99 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154897472 Kiniksa Pharmaceuticals International, plc $20.49 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154897492 Kiniksa Pharmaceuticals International, plc $18.82 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.